Chemomab Therapeutics (CMMB) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.26, -1.94% vs the prior close of $1.29.
- Volume 9.08K shares, 0.1x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CMMB dips 1.9% to $1.26. Closed at $1.26, -1.94% vs the prior close of $1.29. Day range $1.26–$1.35, opened at $1.32.
CMMB daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — CMMB dips 1.9% to $1.26
- Closed at $1.26, -1.94% vs the prior close of $1.29. Day range $1.26–$1.35, opened at $1.32.
- Volume was 9.08K shares, 0.1x its 50-day average of 112.54K — lighter than usual.
- Price is -38.9% vs its 50-day average ($2.07) and -29.3% vs its 200-day average ($1.79).
- 52-week range $1.05–$3.49; today's close sits at 9% of that range, 63.8% below the 52-week high.
Oct 15, 2026 — CMMB ends flat (+0.0%) to $1.29
- Closed at $1.29, +0.00% vs the prior close of $1.29. Day range $1.25–$1.36, opened at $1.29.
- Volume was 21.50K shares, 0.2x its 50-day average of 114.06K — lighter than usual.
- Price is -38.0% vs its 50-day average ($2.08) and -28.0% vs its 200-day average ($1.79).
- 52-week range $1.05–$3.50; today's close sits at 10% of that range, 63.1% below the 52-week high.
Oct 14, 2026 — CMMB jumps 4.0% to $1.29
- Closed at $1.29, +4.03% vs the prior close of $1.24. Day range $1.26–$1.35, opened at $1.26.
- Volume was 25.80K shares, 0.2x its 50-day average of 114.32K — lighter than usual.
- Price is -38.3% vs its 50-day average ($2.09) and -28.0% vs its 200-day average ($1.79).
- 52-week range $1.05–$3.50; today's close sits at 10% of that range, 63.1% below the 52-week high.
Oct 13, 2026 — CMMB slides 10.8% to $1.24
- Closed at $1.24, -10.79% vs the prior close of $1.39. Day range $1.24–$1.41, opened at $1.37.
- Volume was 49.80K shares, 0.4x its 50-day average of 114.87K — lighter than usual.
- Price is -40.9% vs its 50-day average ($2.10) and -30.9% vs its 200-day average ($1.80).
- 52-week range $1.05–$3.50; today's close sits at 8% of that range, 64.6% below the 52-week high.
Oct 12, 2026 — CMMB rises 0.7% to $1.39
- Closed at $1.39, +0.72% vs the prior close of $1.38. Day range $1.38–$1.46, opened at $1.38.
- Volume was 17.20K shares, 0.1x its 50-day average of 115.13K — lighter than usual.
- Price is -34.0% vs its 50-day average ($2.11) and -22.7% vs its 200-day average ($1.80).
- 52-week range $1.05–$3.50; today's close sits at 14% of that range, 60.3% below the 52-week high.
Oct 9, 2026 — CMMB dips 0.7% to $1.38
- Closed at $1.38, -0.72% vs the prior close of $1.39. Day range $1.37–$1.47, opened at $1.39.
- Volume was 12.20K shares, 0.1x its 50-day average of 116.04K — lighter than usual.
- Price is -34.6% vs its 50-day average ($2.11) and -23.4% vs its 200-day average ($1.80).
- 52-week range $1.05–$3.55; today's close sits at 13% of that range, 61.1% below the 52-week high.
Oct 8, 2026 — CMMB rises 1.5% to $1.39
- Closed at $1.39, +1.46% vs the prior close of $1.37. Day range $1.36–$1.44, opened at $1.40.
- Volume was 20.60K shares, 0.2x its 50-day average of 119.99K — lighter than usual.
- Price is -34.2% vs its 50-day average ($2.11) and -22.9% vs its 200-day average ($1.80).
- 52-week range $1.05–$3.55; today's close sits at 14% of that range, 60.8% below the 52-week high.
Oct 7, 2026 — CMMB dips 2.1% to $1.37, 3 down days in a row
- Closed at $1.37, -2.14% vs the prior close of $1.40. Day range $1.36–$1.40, opened at $1.38.
- Volume was 10.00K shares, 0.1x its 50-day average of 120.13K — lighter than usual.
- Price is -35.2% vs its 50-day average ($2.11) and -24.1% vs its 200-day average ($1.81).
- 52-week range $1.05–$3.58; today's close sits at 13% of that range, 61.7% below the 52-week high.
- That makes 3 straight losses.
Oct 6, 2026 — CMMB dips 0.7% to $1.40
- Closed at $1.40, -0.71% vs the prior close of $1.41. Day range $1.38–$1.57, opened at $1.57.
- Volume was 25.20K shares, 0.2x its 50-day average of 120.13K — lighter than usual.
- Price is -33.8% vs its 50-day average ($2.11) and -22.6% vs its 200-day average ($1.81).
- 52-week range $1.05–$3.58; today's close sits at 14% of that range, 60.9% below the 52-week high.
Oct 5, 2026 — CMMB dips 1.4% to $1.41
- Closed at $1.41, -1.40% vs the prior close of $1.43. Day range $1.39–$1.49, opened at $1.43.
- Volume was 55.30K shares, 0.5x its 50-day average of 119.87K — lighter than usual.
- Price is -33.3% vs its 50-day average ($2.11) and -22.2% vs its 200-day average ($1.81).
- 52-week range $1.05–$3.58; today's close sits at 14% of that range, 60.6% below the 52-week high.
Oct 2, 2026 — CMMB jumps 10.0% to $1.43
- Closed at $1.43, +10.00% vs the prior close of $1.30. Day range $1.30–$1.43, opened at $1.30.
- Volume was 41.90K shares, 0.3x its 50-day average of 120.39K — lighter than usual.
- Price is -32.3% vs its 50-day average ($2.11) and -21.2% vs its 200-day average ($1.82).
- 52-week range $1.05–$3.58; today's close sits at 15% of that range, 60.1% below the 52-week high.
CMMB latest news & SEC filings
Every SEC filing by or about CMMB in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 30, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 9, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Cohen Neil Harris sold 1,000 shares at $2.80 (≈$2.80K) on Aug 28, 2026
- Cohen Neil Harris sold 1,000 shares at $2.80 (≈$2.80K) on Aug 28, 2026
- Cohen Neil Harris sold 1,000 shares at $2.80 (≈$2.80K) on Aug 28, 2026
- Cohen Neil Harris sold 1,000 shares at $2.80 (≈$2.80K) on Aug 28, 2026
- Cohen Neil Harris sold 1,304 shares at $2.85 (≈$3.72K) on Aug 27, 2026
- Cohen Neil Harris sold 1,304 shares at $2.85 (≈$3.72K) on Aug 27, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 19, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 13, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 10, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 16, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 8, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade CMMB
- Last results release: May 11, 2023 (8-K Item 2.02). Previous ones: Feb 21, 2023, Aug 12, 2022, May 12, 2022. Based on that rhythm, the next report is likely around Aug 10, 2023 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 5.68% (largest 26.1%). That is a volatile stock.
- Liquidity: about 122.89K shares (≈$155.46K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.26 vs a range of $1.05–$3.49 (9% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:4 on Aug 26, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 8 open-market buys, 8 sales; latest: Neil Harris Cohen sold 1,000 shares on Aug 28, 2026.
- Latest filings: 6-K Sep 30, 2026; 6-K Aug 19, 2026; 6-K Jul 8, 2026.
- Share count: 11.05M shares outstanding (May 8, 2023), -3.1% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
CMMB market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.32 | 1.35 | 1.26 | 1.26 | 9.08K |
| Oct 15, 2026 | 1.29 | 1.36 | 1.25 | 1.29 | 21.50K |
| Oct 14, 2026 | 1.26 | 1.35 | 1.26 | 1.29 | 25.80K |
| Oct 13, 2026 | 1.37 | 1.41 | 1.24 | 1.24 | 49.80K |
| Oct 12, 2026 | 1.38 | 1.46 | 1.38 | 1.39 | 17.20K |
| Oct 9, 2026 | 1.39 | 1.47 | 1.37 | 1.38 | 12.20K |
| Oct 8, 2026 | 1.40 | 1.44 | 1.36 | 1.39 | 20.60K |
| Oct 7, 2026 | 1.38 | 1.40 | 1.36 | 1.37 | 10.00K |
| Oct 6, 2026 | 1.57 | 1.57 | 1.38 | 1.40 | 25.20K |
| Oct 5, 2026 | 1.43 | 1.49 | 1.39 | 1.41 | 55.30K |
| Oct 2, 2026 | 1.30 | 1.43 | 1.30 | 1.43 | 41.90K |
| Oct 1, 2026 | 1.25 | 1.40 | 1.25 | 1.30 | 195.40K |
| Sep 30, 2026 | 1.62 | 1.66 | 1.05 | 1.19 | 677.10K |
| Sep 29, 2026 | 1.59 | 1.77 | 1.50 | 1.61 | 437.80K |
| Sep 28, 2026 | 2.20 | 2.22 | 1.61 | 1.64 | 349.80K |
| Sep 25, 2026 | 2.20 | 2.26 | 2.10 | 2.16 | 63.20K |
| Sep 24, 2026 | 2.25 | 2.28 | 2.16 | 2.20 | 97.20K |
| Sep 23, 2026 | 2.41 | 2.41 | 2.16 | 2.28 | 133.50K |
| Sep 22, 2026 | 2.46 | 2.63 | 2.36 | 2.38 | 133.00K |
| Sep 21, 2026 | 2.65 | 2.70 | 2.46 | 2.48 | 82.30K |
About Chemomab Therapeutics
Chemomab Therapeutics (CMMB) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in TEL AVIV. State of incorporation: Israel. Fiscal year ends December 31. SEC CIK 1534248.
CMMB board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Neil Harris Cohen | Director | Sep 1, 2026 |
| Nissim Darvish | Director | Apr 10, 2026 |
| Gwen A Melincoff | Director | Jun 3, 2026 |
| George Adi Mor | Chief Executive Officer | Jun 1, 2026 |
| Alan Charles Moses | Director | Apr 10, 2026 |
| Claude Nicaise | Director | Mar 31, 2026 |
| Jill M. Quigley | Director | Mar 31, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Sigal Fatal | Chief Financial Officer | Apr 10, 2026 |
| John Lawler | Chief Development Officer | Apr 10, 2026 |
| George Adi Mor | Chief Executive Officer | Jun 1, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 28, 2026 | Neil Harris Cohen | Sale | 1,000 | $2.80 |
| Aug 28, 2026 | Neil Harris Cohen | Sale | 1,000 | $2.80 |
| Aug 28, 2026 | Neil Harris Cohen | Sale | 1,000 | $2.80 |
| Aug 28, 2026 | Neil Harris Cohen | Sale | 1,000 | $2.80 |
| Aug 27, 2026 | Neil Harris Cohen | Sale | 1,304 | $2.85 |
| Aug 27, 2026 | Neil Harris Cohen | Sale | 1,304 | $2.85 |
| Aug 27, 2026 | Neil Harris Cohen | Sale | 1,304 | $2.85 |
| Aug 27, 2026 | Neil Harris Cohen | Sale | 1,304 | $2.85 |
| May 29, 2026 | George Adi Mor | Buy | 4,878 | $2.05 |
| May 29, 2026 | George Adi Mor | Buy | 4,926 | $2.08 |
| May 29, 2026 | George Adi Mor | Buy | 4,878 | $2.05 |
| May 29, 2026 | George Adi Mor | Buy | 4,926 | $2.08 |
| May 29, 2026 | George Adi Mor | Buy | 4,878 | $2.05 |
| May 29, 2026 | George Adi Mor | Buy | 4,926 | $2.08 |
| May 29, 2026 | George Adi Mor | Buy | 4,878 | $2.05 |
CMMB financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2022 | — | $-27.65M | 0.12 | $-20.37M |
| Dec 31, 2021 | — | $-12.48M | 0.06 | $-12.37M |
| Dec 31, 2020 | — | $-5.95M | — | $-5.24M |
| Dec 31, 2019 | — | $-27.12M | — | $-16.46M |
| Dec 31, 2018 | — | $-13.80M | — | $-14.22M |
Latest balance sheet: total assets $35.01M, total liabilities $7.06M, cash $20.77M (as of Mar 31, 2023).
CMMB earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| May 11, 2023 | 8-K Item 2.02 (results) | — |
| Feb 21, 2023 | 8-K Item 2.02 (results) | — |
| Aug 12, 2022 | 8-K Item 2.02 (results) | — |
| May 12, 2022 | 8-K Item 2.02 (results) | — |
| Mar 9, 2022 | 8-K Item 2.02 (results) | — |
| Nov 12, 2021 | 8-K Item 2.02 (results) | — |
| Aug 13, 2021 | 8-K Item 2.02 (results) | — |
| May 13, 2021 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on CMMB
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.